Beta Drugs Other Announcement
Beta Drugs Limited submitted its quarterly compliance certificate for the period ended March 31, 2026. The certificate confirms that security certificates received for dematerialisation were processed and the name of the depositories substituted in the register of members within prescribed timelines. This is a routine regulatory filing with no material financial impact.